Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | AMGN | GILD | VRTX | REGN |
| Company | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 47.39 | 273.45 | 67.47 | 402.44 | 911.09 |
| High | 47.50 | 274.35 | 67.90 | 403.88 | 915.00 |
| Low | 45.44 | 270.87 | 66.46 | 397.05 | 892.01 |
| Last | 45.20 | 268.59 | 66.03 | 395.23 | 889.94 |
| Change | -3.66 | -4.42 | -1.05 | -5.53 | -16.60 |
| % Change | -7.49% | -1.62% | -1.57% | -1.38% | -1.83% |
| Volume | 5,432,948 | 139,879 | 905,072 | 73,562 | 70,680 |
| 20-Day Average Volume | 10,742,865 | 2,064,771 | 6,133,932 | 926,730 | 427,972 |
| Previous Close | 48.86 | 273.01 | 67.08 | 400.76 | 906.54 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 50.03 | 270.86 | 68.78 | 402.38 | 922.70 |
| 20-Day Raw Stochastic | 0.74% | 42.57% | 15.68% | 26.64% | 5.16% |
| 20-Day Relative Strength | 32.53% | 47.73% | 33.56% | 43.65% | 35.97% |
| Weighted Alpha | -31.12 | +10.89 | -20.66 | +15.43 | +11.79 |
| Today's Opinion | 88% Sell | 56% Sell | 100% Sell | 8% Buy | 8% Buy |
| Previous Opinion | 88% Sell | 40% Sell | 100% Sell | 8% Buy | 24% Buy |
| Last Month's Opinion | 8% Sell | 24% Buy | 88% Sell | 56% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.87% since 04/18/24 | +3.73% since 04/18/24 | +1.50% since 04/18/24 | +1.43% since 04/18/24 | +0.07% since 04/18/24 |
| Low | 46.37 on 04/25/24 | 260.68 on 04/19/24 | 66.16 on 04/19/24 | 391.25 on 04/19/24 | 891.46 on 04/19/24 |
| High | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 406.86 on 04/23/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | -11.14% since 03/25/24 | -2.94% since 03/25/24 | -7.48% since 03/25/24 | -4.06% since 03/25/24 | -6.92% since 03/25/24 |
| Low | 46.37 on 04/25/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 421.45 on 04/01/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | -6.41% since 01/25/24 | -12.15% since 01/25/24 | -16.30% since 01/25/24 | -7.17% since 01/25/24 | -5.72% since 01/25/24 |
| Low | 46.37 on 04/25/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 890.43 on 04/16/24 |
| High | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -17.98% since 10/25/23 | +0.14% since 10/25/23 | -14.34% since 10/25/23 | +9.94% since 10/25/23 | +12.24% since 10/25/23 |
| Low | 46.37 on 04/25/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 769.19 on 10/27/23 |
| High | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 99,027,448 | 146,436,016 | 83,519,768 | 103,580,040 | 99,503,640 |
| Shares Outstanding, K | 2,026,759 | 536,376 | 1,245,077 | 258,459 | 109,762 |
| Annual Sales | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 3,434,300,000 |
| Last Quarter Net Income | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 1,159,600,000 |
| 60-Month Beta | 0.39 | 0.58 | 0.19 | 0.35 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 | 05/02/24 |
| Most Recent Dividend | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | 04/04/24 | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 6.53 | 14.67 | 9.97 | 30.13 | 24.14 |